Загрузка страницы

Clinical Considerations of Aging People Living with HIV - Marta Boffito

Presenter: Marta Boffito, MD, PhD, FRCP
Lecture: Clinical Considerations of Aging People Living with HIV
Presented in Session 2: Clinical Considerations for Starting and Switching Therapy

GCC HIV Clinical Forum 2022
Subscribe to our newsletter: https://amededu.activehosted.com/f/13
For more information, visit: https://academicmedicaleducation.com/
Upcoming meetings: https://academicmedicaleducation.com/program

Meeting Description
The GCC HIV Clinical Forum 2022 provides an independent scientific program involving the world’s leading experts. It is specifically designed for HIV healthcare professionals in the Gulf region and focuses on optimizing treatment for their patients.

This program will feature challenging plenary lectures followed by ample time for Q&A and debate, stimulating interaction, and knowledge-sharing within the HIV-treating community. The program will also include networking opportunities for community-building, providing delegates with the unique opportunity to meet their colleagues in a focused and scientific setting.

The HIV Clinical Forum is a series of interactive programs that provide an independent scientific program on emerging topics in HIV, involving experts where HIV clinicians and allied healthcare professionals receive updates on the latest developments related to HIV management. Here, they can also share their clinical experience as well as present results from their ongoing and completed cohorts/research programs.

Видео Clinical Considerations of Aging People Living with HIV - Marta Boffito канала Academic Medical Education
Показать
Комментарии отсутствуют
Введите заголовок:

Введите адрес ссылки:

Введите адрес видео с YouTube:

Зарегистрируйтесь или войдите с
Информация о видео
4 января 2023 г. 20:55:04
00:21:32
Другие видео канала
The Road to 95-95-95: Progress in HIV Prevention and Treatment (...) - Gloria Bille, BSc, MAThe Road to 95-95-95: Progress in HIV Prevention and Treatment (...) - Gloria Bille, BSc, MAHIV Vaccines, Where Are We Now? - Nono Mkhize, PhDHIV Vaccines, Where Are We Now? - Nono Mkhize, PhDAdvances in HIV Cure Science - Melissa-Rose Abrahams, PhDAdvances in HIV Cure Science - Melissa-Rose Abrahams, PhDPeople First Charter - Laura WatersPeople First Charter - Laura WatersPeople Living with HIV with Limited Treatment Options - Jürgen Rockstroh, MDPeople Living with HIV with Limited Treatment Options - Jürgen Rockstroh, MDClinical Management of People Living with HIV and Comorbidities (+ CVD) - Jehad Abdalla, MDClinical Management of People Living with HIV and Comorbidities (+ CVD) - Jehad Abdalla, MDLong-Acting Therapeutic Options for HIV Treatment and Prevention: Clinical Data - Sharon WalmsleyLong-Acting Therapeutic Options for HIV Treatment and Prevention: Clinical Data - Sharon WalmsleyThe Long-Acting Pipeline for HIV Treatment - Charles Flexner, MDThe Long-Acting Pipeline for HIV Treatment - Charles Flexner, MDLate-Stage Disease - Ghassan K. Abou-Alfa, MDLate-Stage Disease - Ghassan K. Abou-Alfa, MDState-of-the-Art Lecture: HBV Cure - Geoffrey Dusheiko, MBBS, FCP(SA) FRCSState-of-the-Art Lecture: HBV Cure - Geoffrey Dusheiko, MBBS, FCP(SA) FRCSSymposium 1: ViiV - What’s New in HIV Treatment & Prevention for Youth? - Panel DiscussionSymposium 1: ViiV - What’s New in HIV Treatment & Prevention for Youth? - Panel DiscussionEfficacy and Safety of the 2-Drug Regimen Dolutegravir/Lamivudine (DTG/3TC) in... - Cindy VavroEfficacy and Safety of the 2-Drug Regimen Dolutegravir/Lamivudine (DTG/3TC) in... - Cindy VavroHIV Viral Suppression and Patterns of Drug Resistance Mutations among Adolescents...-Joan RugemalilaHIV Viral Suppression and Patterns of Drug Resistance Mutations among Adolescents...-Joan RugemalilaAntiviral PK 2022 - #3 Pharmacokinetics of the Small Interfering RNA (siRNA) (...) - Thomas KakudaAntiviral PK 2022 - #3 Pharmacokinetics of the Small Interfering RNA (siRNA) (...) - Thomas KakudaLong COVID - What Have We Learned So Far? - Carlos del Rio, MDLong COVID - What Have We Learned So Far? - Carlos del Rio, MDUpdate on COVID-19 Therapeutics -  Daniel Kuritzkes, MDUpdate on COVID-19 Therapeutics - Daniel Kuritzkes, MDCMV and Inflammaging in People with HIV - Sara Gianella Weibel, MD (She/Her)CMV and Inflammaging in People with HIV - Sara Gianella Weibel, MD (She/Her)Post Viral Syndrome - Epstein-Barr Virus - Timothy Henrich, MDPost Viral Syndrome - Epstein-Barr Virus - Timothy Henrich, MDAbstract 2: Clinical Rebound of COVID-19 Following Nirmatrelvir/Ritonavir Is (...) - Brian EplingAbstract 2: Clinical Rebound of COVID-19 Following Nirmatrelvir/Ritonavir Is (...) - Brian EplingAbstract 1: Impact of Innate Immunity, Endothelial Damage, and Metabolic (...) - Joseph RoccoAbstract 1: Impact of Innate Immunity, Endothelial Damage, and Metabolic (...) - Joseph Rocco
Яндекс.Метрика